Botanical species · safety record
Daphne genkwa
The EFSA Compendium of Botanicals holds 16 constituent measurements, 7 adverse-effect records and 1 genotoxicity assay for Daphne genkwa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Daphne genkwa Siebold & Zucc.
Also recorded as
Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Daphne genkwa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Daphnane diterpenes3
- Coumarins2
- Yuanhuapine2
- Benzofurans1
- Elemicin1
- Furfural1
- Lignans1
- Methyleugenol1
- Yuanhuacine1
- Yuanhuadine1
Plant parts
- Bud16
- Flower4
- Roots and other underground parts1
- Stem1
- stalk1
Preparations
- Solvent extraction12
- Essential oil4
- Powder1
Effect types
- Systemic4
- Hepatotoxicity2
- Reproductive1
Target tissues
- Liver2
- Respiratory1
- Urogenital1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Benzofurans | Flower | Essential oil | 2.7 Percent | GC-FID | Resolve DOI |
| Daphnane diterpenes | Bud | Solvent extraction | — | LC-MS | Resolve DOI |
| Daphnane diterpenes | Bud | — | — | Unspecified | Resolve DOI |
| Daphnane diterpenes | Bud | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Elemicin | Flower | Essential oil | 4.5 Percent | GC-FID | Resolve DOI |
| Furfural | Flower | Essential oil | 2.8 Percent | GC-FID | Resolve DOI |
| Lignans | Bud | Powder | — | LC-MS | Resolve DOI |
| Methyleugenol | Flower | Essential oil | 4.6 Percent | GC-FID | Resolve DOI |
| Yuanhuacine | Bud | Solvent extraction | 7.4 Milligram/gram | LC-MS | Resolve DOI |
| Yuanhuadine | Bud | Solvent extraction | 10.7 Milligram/gram | LC-MS | Resolve DOI |
| Yuanhuafin | Bud | Solvent extraction | 1.97 Milligram/gram | LC-MS | Resolve DOI |
| Yuanhuapine | Bud | — | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Yuanhuapine | Bud | Solvent extraction | 1.31 Milligram/gram | LC-MS | Resolve DOI |
| Yuanhuatine | Bud | Solvent extraction | 1.04 Milligram/gram | LC-MS | Resolve DOI |
| Coumarins | Stem / stalk | Solvent extraction | — | Unspecified | No resolvable identifier |
| Coumarins | Roots and other underground parts | — | — | Unspecified | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Hepatotoxicity | Liver | Bud | Solvent extraction | Rat (as animal) | Acute toxicity | Resolve DOI |
| Hepatotoxicity | Liver | Bud | Solvent extraction | Rat (as animal) | Acute toxicity | Resolve DOI |
| Reproductive | Urogenital | Bud | Solvent extraction | — | In vitro | Resolve DOI |
| Systemic | Respiratory | Bud | Solvent extraction | Rat (as animal) | Acute toxicity | Resolve DOI |
| Systemic | — | Bud | — | Rat (as animal) | Acute toxicity | Resolve DOI |
| Systemic | — | Bud | — | Rat (as animal) | Acute toxicity | Resolve DOI |
| Systemic | — | — | — | House mouse (as animal) | Acute toxicity | Resolve DOI |
Genotoxicity testing
Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.
| Outcome | Endpoint | Test | Tested organism | Metabolic activation | Source |
|---|---|---|---|---|---|
| Positive | gene mutation | bacterial reverse mutation assay | Salmonella typhimurium (as organism) | — | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Zhang, Yuanyuan., Zhang, Ruowen., Yuan, Yang., Geng, Lulu., Zhao, Xu., Meng, Xia., Zhuang, Hefei., Bi, Kaishun., Chen, Xiaohui. Simultaneous determination of eight active components in chloroform extracts from raw and vinegar-processed Genkwa flos using HPLC-MS and identification of the hepatotoxic ingredients with an HL-7702 cell . Analytical methods, 2014, vol. 6, no. 17, p. 7022-7029. DOI
- Yun, Jun-Won., Kim, Seung-Hyun., Kim, Yun-Soon., You, Ji-Ran., Kwon, Euna., Jang, Ja-June., Park, In Ae., Kim, Hee Chan., Kim, Hyeon Hoe., Che, Jeong-Hwan., Kang, Byeong-Cheol. Evaluation of subchronic (13 week) toxicity and genotoxicity potential of vinegar-processed Genkwa Flos . Regulatory toxicology and pharmacology, 2015, vol. 72, no. 2, p. 386-393. DOI
- Chen, Yan-Yan., Guo, Jian-Ming., Qian, Ye-Fei., Guo, Sheng., Ma, Chun-Hua., Duan, Jin-Ao. Toxicity of daphnane-type diterpenoids from Genkwa Flos and their pharmacokinetic profile in rat . Phytomedicine, 2013, vol. 21, no. 1, p. 82-89. DOI
- Chen, Yanyan., Guo, Jianming., Tang, Yuping., Wu, Liang., Tao, Weiwei., Qian, Yefei., Duan, Jin-ao. Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry . Journal of pharmaceutical and biomedical analysis, 2015, vol. 112, p. 60-69. DOI
- Ueyama, Y., Hashimoto, S., Nii, H., Furukawa, K. The chemical composition of the essential oil of Daphne genkwa sieb. et zucc.. Journal of essential oil research, 1990, vol. 2, no. 5, p. 247-250. DOI
- Li, Lin-Yan., Cao, Fen-Fang., Su, Zhi-Jian., Zhang, Qi-Hao., Dai, Xiao-Yong., Xiao, Xue., Huang, Ya-Dong., Zheng, Qing., Xu, Hua. Assessment of the embryotoxicity of four Chinese herbal extracts using the embryonic stem cell test . Molecular medicine reports, 2015, vol. 12, no. 2, p. 2348-2354. DOI
- Kang, Ho-Bum., Lee, Ha-Reum., Jee, Da Jung., Shin, Su-Hyun., Nah, Seong-Su., Yoon, Sun Young., Kim, Jae Wha. PRDM1, a Tumor-Suppressor Gene, is Induced by Genkwadaphnin in Human Colon Cancer SW620 Cells . Journal of cellular biochemistry, 2016, vol. 117, no. 1, p. 172-179. DOI
- Zhan, ZJ., Fan, CQ., Ding, J., Yue, HM. Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa . Bioorganic & medicinal chemistry, 2005, vol. 13, no. 3, p. 645-655. DOI
- He, Lei., Shi, Qi-rong., Liu, Run-hui., Xu, Xi-ke., Shen, Yun-heng., Li, Hui-liang., Zhang, Wei-dong. Coumarins from the branches of Daphne genkwa. Yaoxue shijian zazhi, 2008, vol. 26, no. 6, p. 441-443.
- Shi, Feng., Zheng, Wei-fa. Phenolic constituents from the roots of Daphne genkwa and their immunomodulatory activity. Xuzhou shifan daxue xuebao, ziran kexueban, 2004, vol. 22, no. 4, p. 34-40.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.